| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6200182 | Ophthalmology | 2016 | 13 Pages |
Abstract
Three-week topical 0.1% fluorometholone therapy is effective not only in reducing ocular surface signs in DED patients, but also especially in preventing exacerbation caused by exposure to a desiccating stress.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
José MSc, Alberto PhD, MarÃa J. PhD, Itziar PhD, Alberto MSc, Amalia PhD, Michael E. PhD, Margarita MD, PhD,